Raphael Wolfisberg, Caroline E. Thorselius, Eduardo Salinas, Elizabeth Elrod, Sheetal Trivedi, Louise Nielsen, Ulrik Fahnøe, Amit Kapoor, Arash Grakoui, Charles M. Rice, Jens Bukh, Kenn Holmbeck, Troels K. H. Scheel – 20 April 2022
Harshad Devarbhavi, Sunu Sara Kurien – 20 April 2022
Erica Fagelman, Ryan Wang, Amanda Tomlinson, Diana Romano, Nicolette Schlichting, Jeron Zerillo, Samuel DeMaria,, Natalie K. Smith – 20 April 2022 – This study characterizes incidence and outcomes surrounding intracardiac thrombosis (ICT) during liver transplantation over 9 years at a single center before and after the routine use of transesophageal echocardiography (TEE). Adult liver transplantation patients from 2011 to 2020 were divided into eras based on routine TEE use. ICTs were identified by querying anesthetic records for search terms.
Monica Tincopa – 20 April 2022
Mila Bukova, Dominik Funken, Eva‐Doreen Pfister, Ulrich Baumann, Nicolas Richter, Florian F. W. Vondran, Christoph M. Happel, Harald Bertram – 20 April 2022 – This study aims to evaluate the long‐term efficacy and reintervention rate after primary percutaneous portal vein stent angioplasty for portal vein stenosis (PVS) in pediatric liver transplantation (LT) recipients. From 2004 to 2020, a total of 470 pediatric LTs were performed in our center. All cases were screened for interventional PVS treatment and analyzed retrospectively.
Zhewen Ren, Pomme I. H. G. Simons, Anke Wesselius, Coen D. A. Stehouwer, Martijn C. G. J. Brouwers – 19 April 2022
Wilson disease (WD; also known as hepatolenticular degeneration) was first described in 1912 by Kinnear Wilson as “progressive lenticular degeneration,” a familial, lethal neurological disease accompanied by chronic liver disease leading to cirrhosis.
Previous guidelines reviewing vascular disorders of the liver focused on thrombosis of large vessels, such as the portal vein (PV) and hepatic vein (HV)
Transjugular Intrahepatic Portosystemic Shunt (TIPS) has been in use for more than 20 years to treat the complications of portal hypertension and TIPS have been created in thousands of patients with liver disease worldwide.